These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 7387270

  • 1. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
    Fass RJ.
    Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic use in neonatal sepsis.
    Yurdakök M.
    Turk J Pediatr; 1998 Jun; 40(1):17-33. PubMed ID: 9722468
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
    Bujdáková H, Kallová J, Lausová A, Kettner M.
    Microbios; 1995 Jun; 84(339):87-90. PubMed ID: 8628124
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro activity of Ro 09-1428, a novel cephalosporin with a catechol moiety.
    Qadri SM, Ayub A, Ueno Y, Saldin H.
    Clin Ther; 1992 Jun; 14(4):562-9. PubMed ID: 1525790
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activities of third-generation cephalosporins.
    Fass RJ.
    Arch Intern Med; 1983 Sep; 143(9):1743-5. PubMed ID: 6615095
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M, Brandimarte C, Santini C, Valente B, Martino P, Serra P.
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [Abstract] [Full Text] [Related]

  • 7. [On the combination of clindamycin with beta-lactam antibiotics and aminoglycosides (author's transl)].
    Adam D, Nawrath I.
    Arzneimittelforschung; 1981 Aug; 31(8):1295-8. PubMed ID: 7197536
    [Abstract] [Full Text] [Related]

  • 8. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF, Alagia I, Giaquinto E, Giordano B, Leonessa V, Altucci P.
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T, Mitsuhashi S.
    Arzneimittelforschung; 1977 Dec; 27(1):89-93. PubMed ID: 576821
    [Abstract] [Full Text] [Related]

  • 10. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT, Andriole VT.
    Yale J Biol Med; 1980 Dec; 53(2):149-59. PubMed ID: 6446810
    [Abstract] [Full Text] [Related]

  • 11. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
    Cluzel M, Chanal M, Sirot J, Cluzel R.
    Nouv Presse Med; 1982 Nov 18; 11(46):3400-4. PubMed ID: 6818523
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL, Jacobus NV, Tally FP, Gorbach SL.
    Clin Ther; 1983 Nov 18; 5(6):603-16. PubMed ID: 6313195
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Sensitivity to mezlocillin Gram-negative aerobic bacilli according to their pattern of resistance to the usual beta-lactam antibiotics (author's transl)].
    Witchitz JL, Faurisson F, Christol D.
    Nouv Presse Med; 1982 Feb 04; 11(5 Pt 2):314-7. PubMed ID: 6460966
    [Abstract] [Full Text] [Related]

  • 15. [Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains (author's transl)].
    Grimm H.
    Arzneimittelforschung; 1982 Feb 04; 32(6):595-7. PubMed ID: 6214262
    [Abstract] [Full Text] [Related]

  • 16. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
    Bell JM, Turnidge JD, Cefepime Study Group.
    Pathology; 2001 Feb 04; 33(1):53-60. PubMed ID: 11280610
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic considerations in using combinations of newer beta-lactam antibiotics.
    Barriere SL.
    Clin Pharm; 1986 Jan 04; 5(1):24-33. PubMed ID: 3512153
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1983 Jul 04; 36(7):1621-37. PubMed ID: 6317908
    [Abstract] [Full Text] [Related]

  • 19. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan 04; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

  • 20. [Study of "in vitro" susceptibility of "Mycobacterium fortuitum" to aminoglycoside and beta-lactam antibiotics (author's transl)].
    Casal M, Rodriguez F.
    Ann Microbiol (Paris); 1981 Jan 04; 132B(1):51-6. PubMed ID: 7305191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.